Roivant Sciences Ltd.

CIK 1635088 · last filed 2025-12-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.98B

Companies

6

Total Filings

34

Lifetime Open-Market Net

$940.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMVT Director 113,317,007 $33.62 $3.81B $759.94M 7 2025-12-12
ABUS 10%+ Owner 38,847,462 $4.26 $165.49M $0 3 2021-10-20
Immunovant, Inc. (IMVTW) Delisted 10%+ Owner 47,213,419 $15.00M 3 2020-05-14
Sio Gene Therapies Inc. (AXGT) Delisted 10%+ Owner 18,577,380 $20.00M 1 2020-02-27
Urovant Sciences Ltd. (UROV) Delisted 10%+ Owner 22,860,013 $16.24 $371.25M $38.75M 10 2019-12-31
Myovant Sciences Ltd. (MYOV) Delisted 10%+ Owner 44,895,145 $26.98 $1.21B $106.37M 7 2019-12-31

Recent Filings · Page 4 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-07 Buy (P) +14,285,714 $25.00M
2018-04-04 Myovant Sciences Ltd. (MYOV) Delisted Buy (P) +1,110,015 $22.50M EDGAR
2018-01-16 ABUS Buy (P) $0 EDGAR
2017-10-17 ABUS Buy (P) $0 EDGAR
Showing 3134 of 34
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.